Abstract
P397 Quality of life of Crohn’s disease patients under immunosuppressive therapy in Germany preliminary results of the DaLi study M. Reinshagen1 *, B. Bokemeyer2, T. Krummenerl3, M.R. Mross4, P. Nurwakagari5, M. Schwarz5, B.M. Wittig5. 1Klinikum Braunschweig, Dep. of Medicine I, Braunschweig, Germany, 2Gastroenterology Practice, Minden, Germany, 3Gastroenterology Center at Germania Campus, Muenster, Germany, 4Gastroenterology Practice, Berlin, Germany, 5Abbott GmbH & Co. KG, Medical Department, Wiesbaden, Germany
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
